🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate statistical superiority of the combination of latanoprost an...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-07
Trial ID
NCT00159653
To demonstrate the statistical non inferiority of the combination of latano...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-07
Trial ID
NCT00140049
The objective of the study is to assess the efficacy and safety of T2347 (L...
Status
Completed
Location
Laboratoires Thea
Start Date
2014-12
Trial ID
NCT02278614
To demonstrate superiority of DuoTrav APS over XALACOM® in Ocular Surface H...
Status
Terminated
Location
Cliniques Universitaires Saint Luc
Start Date
2010-03
Trial ID
NCT00912054
Treatments Being Tested
This study is designed to evaluate the safety and tolerability of Xalacom i...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-10
Trial ID
NCT00801437
Treatments Being Tested
To determine the predictive factors of a positive response to latanoprost 0...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-09
Trial ID
NCT00230763
Treatments Being Tested
The primary objective of this crossover trial is to compare the 3-month, me...
Status
Completed
Location
Glaucoma Unit, 1st University Department of Ophthalmology
Start Date
2012-01
Trial ID
NCT01779284
Treatments Being Tested
Glaucoma is one of the most common causes of blindness in the industrialize...
Status
Completed
Location
Department of Clinical Pharmacology
Start Date
2006-01
Trial ID
NCT00706927
The objective of this Investigation is to evaluate the safety and efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01191008
Treatments Being Tested
Hypothesis: * H1: Efficacy of Duotrav will be superior to Xalacom at 24 ho...
Status
Completed
Location
Ophthalmic Consultant Centres
Start Date
2009-01
Trial ID
NCT00887029
Treatments Being Tested